The Topic of the Webinar

Covid- 19 Crisis Impact on Pricing & Regulation

The COVID-19 crisis elevated both the matter of excessive pricing/price gouging as well as the question of access and affordability regarding treatment and vaccines, which the webinar seeks to address from various perspectives. 

Organized by

Centre for Advanced Studies in Biomedical Innovation Law at Faculty of Law, University of Copenhagen

The conference is organized by the Center for Advanced Studies in Biomedical Innovation Law, Faculty of Law, Copenhagen University with a generous grant from the Novo Nordisk Foundation. 

Date of Webinar

26th January 2021

Registration Fees: NIL

Participation is open to all and free of charge but registration is required.
Please use this form for registration no later than 13:00 January 26th, 2021. 

To Register, Click Here

Preliminary Program

14:00-14:10      

Welcome and Opening remarks

Timo Minssen, CeBIL, Faculty of Law, Copenhagen

14:10-14:30

Keynote: Don’t Do This: Lessons from Regulation and Pricing of COVID-19 Products in the US

Aaron Kesselheim, Harvard University

14:30-14:50

Keynote: COVID-19, Global Acces & Affordability

Martin Wenzel, OECD
14:50-15:00BREAK

15:00-15:30

COVID 19 and Excessive Pricing

Elisabetta Lanza, Italian Competition Authority;
Luca Arnaudo, Italian Medicine Agency;
Rossi Pencheva, UK Competition and Market Authority

15:30-16:15

Excessive Pricing in Pharma - past & future

Rainer Becker, European Commission, DG Comp;
Lene Thomsen Andrä, Danish Competition and Consumer Authority;
Behrang Kianzad, CeBIL, Faculty of Law, Copenhagen

16:15-16:30BREAK

16:30-16:50

Innovation & Affordability Interface

Ancel-la Santos, Senior Health Policy Officer, (BEUC);
Agustin Reyna, Director, Legal and Economic Affairs, (BEUC)

16:50-17:20Open Discussion

17:20-17:30

Closing Remarks

Timo Minssen, CeBIL, Faculty of Law, Copenhagen

Contact Information
For Official Notification, Click Here